KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, updates its shareholders on the clinical progress and corporate developments the company achieved during 2011. The company also provides insight on its accomplishments and plans for the first part of 2012.
